XML 17 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Financial Information (Consolidated Statements Of Cash Flows) (Details) (USD $)
In Millions, unless otherwise specified
6 Months Ended
Aug. 02, 2014
Aug. 03, 2013
Net Cash Provided by Operating Activities $ 446 $ 354
Investing Activities:    
Capital Expenditures (349) (383)
Other Investing Activities 15 2
Net Cash Provided by (Used for) Investing Activities (334) (381)
Financing Activities:    
Borrowings from Revolving Facility 5 0
Repayments on Revolving Facility (5) 0
Repurchase of Common Stock (48) (55)
Dividends Paid (491) (174)
Excess Tax Benefits from Share-based Compensation 37 25
Net Financing Activities and Advances to/from Consolidated Affiliates 0 0
Proceeds from Exercise of Stock Options and Other 22 10
Payments of Financing Costs (5) 0
Net Cash Provided by (Used for) Financing Activities (485) (194)
Effects of Exchange Rate Changes on Cash and Cash Equivalents 1 (1)
Net Increase (Decrease) in Cash and Cash Equivalents (372) (222)
Cash and Cash Equivalents, Beginning of Period 1,519 773
Cash and Cash Equivalents, End of Period 1,147 551
L Brands, Inc.
   
Net Cash Provided by Operating Activities (172) (153)
Investing Activities:    
Capital Expenditures 0 0
Other Investing Activities 0 0
Net Cash Provided by (Used for) Investing Activities 0 0
Financing Activities:    
Borrowings from Revolving Facility 0  
Repayments on Revolving Facility 0  
Repurchase of Common Stock (48) (55)
Dividends Paid (491) (174)
Excess Tax Benefits from Share-based Compensation 0 0
Net Financing Activities and Advances to/from Consolidated Affiliates 694 372
Proceeds from Exercise of Stock Options and Other 22 10
Payments of Financing Costs 5  
Net Cash Provided by (Used for) Financing Activities 172 153
Effects of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase (Decrease) in Cash and Cash Equivalents 0 0
Cash and Cash Equivalents, Beginning of Period 0 0
Cash and Cash Equivalents, End of Period 0 0
Guarantor Subsidiaries
   
Net Cash Provided by Operating Activities 488 426
Investing Activities:    
Capital Expenditures (248) (266)
Other Investing Activities 0 0
Net Cash Provided by (Used for) Investing Activities (248) (266)
Financing Activities:    
Borrowings from Revolving Facility 0  
Repayments on Revolving Facility 0  
Repurchase of Common Stock 0 0
Dividends Paid 0 0
Excess Tax Benefits from Share-based Compensation 31 21
Net Financing Activities and Advances to/from Consolidated Affiliates (704) (292)
Proceeds from Exercise of Stock Options and Other 0 0
Financing Costs 0  
Net Cash Provided by (Used for) Financing Activities (673) (271)
Effects of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase (Decrease) in Cash and Cash Equivalents (433) (111)
Cash and Cash Equivalents, Beginning of Period 1,353 417
Cash and Cash Equivalents, End of Period 920 306
Non- guarantor Subsidiaries
   
Net Cash Provided by Operating Activities 130 81
Investing Activities:    
Capital Expenditures (101) (117)
Other Investing Activities 15 (2)
Net Cash Provided by (Used for) Investing Activities (86) (115)
Financing Activities:    
Borrowings from Revolving Facility 5  
Repayments on Revolving Facility (5)  
Repurchase of Common Stock 0 0
Dividends Paid 0 0
Excess Tax Benefits from Share-based Compensation 6 4
Net Financing Activities and Advances to/from Consolidated Affiliates 10 (80)
Proceeds from Exercise of Stock Options and Other 0 0
Financing Costs 0  
Net Cash Provided by (Used for) Financing Activities 16 (76)
Effects of Exchange Rate Changes on Cash and Cash Equivalents 1 (1)
Net Increase (Decrease) in Cash and Cash Equivalents 61 (111)
Cash and Cash Equivalents, Beginning of Period 166 356
Cash and Cash Equivalents, End of Period 227 245
Eliminations
   
Net Cash Provided by Operating Activities 0 0
Investing Activities:    
Capital Expenditures 0 0
Other Investing Activities 0 0
Net Cash Provided by (Used for) Investing Activities 0 0
Financing Activities:    
Borrowings from Revolving Facility 0  
Repayments on Revolving Facility 0  
Repurchase of Common Stock 0 0
Dividends Paid 0 0
Excess Tax Benefits from Share-based Compensation 0 0
Net Financing Activities and Advances to/from Consolidated Affiliates 0 0
Proceeds from Exercise of Stock Options and Other 0 0
Financing Costs 0  
Net Cash Provided by (Used for) Financing Activities 0 0
Effects of Exchange Rate Changes on Cash and Cash Equivalents 0 0
Net Increase (Decrease) in Cash and Cash Equivalents 0 0
Cash and Cash Equivalents, Beginning of Period 0 0
Cash and Cash Equivalents, End of Period $ 0 $ 0